Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/29/1997 | CN1163146A Cardio-sodium complementary DNA eucaryon expression plasmid component and its muscle introduction therapy |
10/28/1997 | US5681946 Precipitating polymers |
10/28/1997 | US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited |
10/28/1997 | US5681942 Fanconi Anemia Type C gene |
10/28/1997 | US5681941 Substituted purines and oligonucleotide cross-linking |
10/28/1997 | US5681940 Sugar modified nucleosides and oligonucleotides |
10/28/1997 | US5681933 Immunizing animal with interleukin |
10/28/1997 | US5681932 Method of using eukaryotic expression vectors comprising the BK virus |
10/28/1997 | US5681818 Therapeutic uses of human somatomedin carrier proteins |
10/28/1997 | US5681809 Growth hormone antagonists |
10/28/1997 | US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof |
10/28/1997 | US5681746 Genetic engineering |
10/28/1997 | US5681745 Biotin-binding containment systems |
10/28/1997 | US5681744 Delivery and expression of heterologus genes using upstream enhancer regions of mammalian gene promoters |
10/28/1997 | US5681737 Detection system for mutagens that also identifies mutagenic changes |
10/28/1997 | US5681735 Transcription control element for increasing gene expression in myoblasts |
10/28/1997 | US5681733 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum |
10/28/1997 | US5681732 Cloning and expression of acetyl xylan esterases from fungal origin |
10/28/1997 | US5681731 Adeno-associated virus transducing vector having cellular tropism of different parvovirus, comprising gene encoding capsid protein of said parvovirus, other exogenous genetic material |
10/28/1997 | US5681730 Particle-mediated transformation of gymnosperms |
10/28/1997 | US5681729 Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby |
10/28/1997 | US5681726 Method of double stranded DNA synthesis |
10/28/1997 | US5681725 Culturing an apoprotein producing microorganism in a fermentation media |
10/28/1997 | US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof |
10/28/1997 | US5681723 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
10/28/1997 | US5681721 Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect |
10/28/1997 | US5681720 DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide |
10/28/1997 | US5681719 Genetic engineering |
10/28/1997 | US5681717 Isolated dna sequence from brevibacterium is used for genetic engineering of other bacteria which can produce desired amino acids or nucleic acids as culture products |
10/28/1997 | US5681716 Nucleic acid sequences from Salmonella typhi for in vitro diagnosis in foodstuffs |
10/28/1997 | US5681715 Process for preparing lipases |
10/28/1997 | US5681714 Nucleic acid encoding tek receptor tyrosine kinase |
10/28/1997 | US5681713 Genetic engineering |
10/28/1997 | US5681708 Dissociate protein-protein complex |
10/28/1997 | US5681706 Mammalian anoxia-responsive regulatory element |
10/28/1997 | US5681705 Amplification and detection of mycobacterium avium complex species |
10/28/1997 | US5681702 Reduction of nonspecific hybridization by using novel base-pairing schemes |
10/28/1997 | US5681701 Testing a drug by exposing a culture of the osteoblastic cells which express a temperature sensitive mutant of simian virus large t antigen to the drug and monitoring the effect |
10/28/1997 | US5681697 Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor |
10/28/1997 | US5681587 Contacting with laminin |
10/28/1997 | US5681562 Lymphokine gene therapy of cancer |
10/28/1997 | US5681534 High throughput oligonucleotide synthesizer |
10/28/1997 | CA1339515C Diagnostic system for the detection of cytomegalovirus |
10/26/1997 | CA2199582A1 Cpc gene for regulating initiation of root hair formation for arabidopsis (thaliana), and transgenic (arabidopsis) plant overexpressing the cpc gene |
10/23/1997 | WO1997039151A1 Photolabile polymer array synthesis methods |
10/23/1997 | WO1997039139A1 A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer |
10/23/1997 | WO1997039138A1 Multiplex amplification of short tandem repeat loci |
10/23/1997 | WO1997039135A1 Enhanced expression of transgenes |
10/23/1997 | WO1997039134A1 Virus-like particle |
10/23/1997 | WO1997039133A1 Novel neuronal cell growth factor |
10/23/1997 | WO1997039131A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
10/23/1997 | WO1997039130A2 Method for expressing and secreting keratinase |
10/23/1997 | WO1997039129A1 Non-a-non-e hepatitis virus having a translatable core region, reagents and methods for their use |
10/23/1997 | WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection |
10/23/1997 | WO1997039127A1 Hybrid interferon compositions and methods of use |
10/23/1997 | WO1997039126A1 Novel rantes homolog from prostate |
10/23/1997 | WO1997039125A1 Antibodies against the advanced glycosylation end-product receptor and uses thereof |
10/23/1997 | WO1997039124A1 Cytoplasmic modulators of integrin regulation/signaling |
10/23/1997 | WO1997039123A2 Secreted proteins |
10/23/1997 | WO1997039122A2 ISOLATED AND CLONED MAST CELL 78 kDa PHOSPHOPROTEIN (MAST CELL DEGRANULATION INHIBITORY AGENT) AND USE THEREOF |
10/23/1997 | WO1997039121A1 Advanced glycosylation end-product receptor peptides and uses therefor |
10/23/1997 | WO1997039120A2 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
10/23/1997 | WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression |
10/23/1997 | WO1997039117A1 Conditionally immortalised cell lines derived from transgenic animals |
10/23/1997 | WO1997039113A1 Biologically active fragment of bacillus stearothermophilus dna polymerase |
10/23/1997 | WO1997039112A1 NOVEL PLANT STEROID 5α REDUCTASE, DET2 |
10/23/1997 | WO1997039110A1 Transgenic plants expressing geminivirus genes |
10/23/1997 | WO1997039106A1 Methods and tools for transformation of eukaryotic algae |
10/23/1997 | WO1997039102A2 Secreted proteins |
10/23/1997 | WO1997039030A2 Secreted proteins |
10/23/1997 | WO1997039029A2 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
10/23/1997 | WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
10/23/1997 | WO1997039022A1 Novel compounds |
10/23/1997 | WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
10/23/1997 | WO1997039019A1 Novel cationic cholesteryl derivatives containing cyclic polar groups |
10/23/1997 | WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE |
10/23/1997 | WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
10/23/1997 | WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE |
10/23/1997 | WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE |
10/23/1997 | WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
10/23/1997 | WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
10/23/1997 | WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
10/23/1997 | WO1997039008A1 Detection probes, kits and assays |
10/23/1997 | WO1997038729A1 In vivo gene transfer methods for wound healing |
10/23/1997 | WO1997038728A1 Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil |
10/23/1997 | WO1997038723A1 Targeted viral vectors |
10/23/1997 | WO1997038722A1 Novel compounds |
10/23/1997 | WO1997038721A1 Novel compounds |
10/23/1997 | WO1997038720A1 Novel compounds |
10/23/1997 | WO1997038719A1 Novel compounds |
10/23/1997 | WO1997038718A1 Novel compounds |
10/23/1997 | WO1997038717A1 Novel compounds |
10/23/1997 | WO1997038716A1 Novel compounds |
10/23/1997 | WO1997038715A1 Novel compounds |
10/23/1997 | WO1997038714A1 Novel compounds |
10/23/1997 | WO1997038712A1 Intestinal trefoil proteins |
10/23/1997 | WO1997038710A1 Synthesis of human procollagens and collagens in recombinant dna systems |
10/23/1997 | WO1997038703A1 Chimeric isoprenoid synthases and uses thereof |
10/23/1997 | WO1997038588A1 Food products containing structured triglycerides |
10/23/1997 | WO1997038587A1 Methods for producing dairy products, in particular cheese using lactic acid bacteria provided with additional neutral protease activity |